DrugPatentWatch Database Preview
Profile for European Patent Office Patent: 2698152
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2698152
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Oct 14, 2029 | Boehringer Ingelheim | GLYXAMBI | empagliflozin; linagliptin |
➤ Try a Free Trial | Oct 14, 2029 | Boehringer Ingelheim | JARDIANCE | empagliflozin |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |